SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NAOV is trending following the grant of a new U.S. patent for its ENvue Medical subsidiary, which covers systems guiding medical device insertion using electromagnetic positioning. The community is discussing the stock's potential for further gains, consolidation patterns, and key price levels to watch, while also referencing the stock's low float and potential for a short squeeze.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid excitement surrounding its potential role in powering AI data centers and a new partnership with ABB, though some express concern about its high valuation and lack of revenue. Community discussions include potential price targets and comparisons to other nuclear companies, while others point to past news of share offerings as a cautionary sign. The stock's volatile price action is also a hot topic, with some traders looking to capitalize on short-term swings.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential pivot towards AI/HPC, with some suggesting the company is undervalued compared to competitors like IREN. Community members are debating whether the company can successfully transition and capitalize on the AI/HPC trend, while others focus on short-term price movements and potential short squeezes.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as the community discusses the potential impact of Vice President JD Vance hosting a show on the platform and all time high short interest. Chatter revolves around a possible short squeeze, the upcoming Rumble wallet, and the pending Northern Data acquisition. Investors are also weighing the company's ties to figures and events associated with a former U.S. president.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is experiencing significant volatility, driven by speculation around a potential SOL treasury announcement. The community is actively discussing potential price targets and whether the stock is experiencing a pump and dump, while others highlight a possible incoming FDA submission. Some traders are comparing HSDT to other low float runners and weighing the potential for a short squeeze.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending as investors discuss potential short squeezes amidst high short interest and anticipation of upcoming Fed rate decisions. Community members are highlighting institutional accumulation and technical indicators suggesting a breakout. Recent positive analyst ratings and the company's strategic positioning in the mortgage and real estate market with acquisitions like Redfin are also fueling the conversation.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

LVLU is trending due to recent price movement and community speculation about a potential short squeeze, driven by its ultra-low float and high short interest. Traders are actively discussing technical setups, analyst price targets, and comparing it to other low-float runners. Some are awaiting further catalysts, such as news or filings, to fuel further momentum.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is trending due to its strong community and association with the 'We're All Gonna Make It' mantra, creating a movement within the crypto space. The token's presence on the $SOL.X blockchain and $PUMP.X ecosystem is driving increased attention, with community members emphasizing its potential for generational wealth and comparing it to previous memecoin successes like $SHIB.X.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

GLUE is trending due to a licensing agreement with Novartis potentially worth billions, leading to significant upfront payments and future royalties. Community members are debating whether to hold for long-term gains or take profits amidst discussions of short squeezes and potential price targets. The overall sentiment is bullish, driven by the news and the potential for substantial financial upside, though some caution against a possible pullback.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native memecoin with a focus on a fair launch and strong community, differentiating itself from Ethereum and Solana-based alternatives. Community members highlight its organic, decentralized nature and fixed supply, while some suggest potential partnerships could be a catalyst. Sentiment focuses on long-term potential within the Bitcoin ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?

KalVista jumps 36% in a week after the FDA clears Ekterly, the first oral on-demand therapy for hereditary angioedema.

Will Strong Asceniv Sales Drive ADMA Biologics Further? 

ADMA rides on record Asceniv sales and FDA-backed yield boost, but valuation concerns and EPS downgrades cloud its outlook.

Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?

Ocular Therapeutix (OCUL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?

ADMA's surging Asceniv demand and bold revenue forecasts set it apart in the competitive plasma therapies space.

ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?

ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold?

ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock?

The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)

The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary...

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takedas U.S. Business Unit, as the successor to...

Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch...

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Takeda Pharmaceutical Co - ADR

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Current Price	$15.06
Prev Close	$15.10
Open	$15.11
Dividend Yield	3.65%
50-Day Moving Average	$14.81
Beta	0.29
Avg. Volume	3.55M
PE Ratio	49.61

52-Week High	$15.69
52-Week Low	$12.80
Market Capitalization	$47.17B
EPS (Annual)	$0.2242
Price to Book	0.99
Revenue Per Employee	$633,289.19
Enterprise Value/EBITDA	N/A

TAK
Takeda Pharmaceutical Co Ltd (ADR)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TAK News

TAK Takeda Pharmaceutical Co Ltd (ADR)